Treatment with elesclomol at 10 and 20 nM also induced apoptosis more potently in ARID1A-mutant cancer cells than in ARID1A-wildtype cancer cells (P = 0.0227 and P = 0.0057, respectively) (Figure 1d). Here, ARID1A is linked to cancer.